A deeper understanding of the individual and the drive toward personalized medicine has opened new frontiers.

The aging population, combined with extended life expectancy, has generated tremendous demand for all forms of life sciences including medical devices and biotechnology. Additionally, recent progress in detailing the human genome and a deeper understanding of microbial genetics and metabolism, along with the creation of new, cost-effective research tools has created new opportunities. Velocity is actively sourcing early-stage life sciences, medical devices, medical sensors, diagnostics, therapeutics, telehealth and regenerative medicine companies.